The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival in patients with advanced melanoma (MEL) who discontinued treatment with nivolumab (NIVO) plus ipilimumab (IPI) due to toxicity in a phase II trial (CheckMate 069).
 
F. Stephen Hodi
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Michael Andrew Postow
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jason Alan Chesney
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Anna C. Pavlick
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
 
Kenneth F. Grossmann
Consulting or Advisory Role - Roche/Genentech
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Gerald P Linette
No Relationships to Disclose
 
Nicolas Meyer
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Expert Testimony - Amgen; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Jeffrey K. Giguere
No Relationships to Disclose
 
Sanjiv Agarwala
No Relationships to Disclose
 
Montaser F. Shaheen
No Relationships to Disclose
 
Marc S. Ernstoff
Stock and Other Ownership Interests - Bristol-Myers Squibb; CVS CAREMARK; GE Healthcare; Nestle health science; Pfizer
Consulting or Advisory Role - ALKERMES; Bristol-Myers Squibb; Merck
Research Funding - Alkermes; Altor BioScience; Bristol-Myers Squibb; Merck; Polynoma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Myriad Genetics
 
David R. Minor
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Atreca; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Merck
 
April K. Salama
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Abbvie (I); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Matthew H. Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Eisai (Inst); Merck (Inst); Novartis (Inst)
 
Patrick Alexander Ott
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences; Bristol-Myers Squibb; MedImmune; Merck
 
Joel Jiang
No Relationships to Disclose
 
Paul Gagnier
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Abbott Laboratories; Bristol-Myers Squibb; Johnson & Johnson; Merck
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb